Biochemicals and Reagents
Biochemicals and reagents are fundamental substances for research and development in fields such as biotechnology, molecular biology, pharmacology, and medicine. These products are essential for a variety of applications, including compound synthesis, biological sample analysis, metabolic process research, and drug production. At CymitQuimica, we offer a wide selection of high-quality, high-purity biochemicals and reagents suitable for various scientific and industrial needs. Our catalog includes enzymes, antibodies, nucleic acids, amino acids, and many other products, all designed to support researchers and professionals in their research and development projects, ensuring reliable and reproducible results.
Subcategories of "Biochemicals and Reagents"
- Biomolecules(98,574 products)
- By Biological Target(100,726 products)
- By Pharmacological Effects(6,937 products)
- Cryopreservatives(21 products)
- Desinfectants and Related Compounds(28 products)
- Hormones(439 products)
- Plant Biology(6,907 products)
- Secondary Metabolites(14,367 products)
Found 130493 products of "Biochemicals and Reagents"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
R 80123
CAS:R 80123 is a fatty acid derivative that has been shown to have an inhibitory effect on cancer cells. This drug also has cardiac effects, which are the result of its ability to increase the heart's contractility. R 80123 may also be helpful in treating inflammatory bowel disease because it has been shown to inhibit the production of pro-inflammatory cytokines (e.g., TNF-α) and reduce the production of reactive oxygen species by macrophages. It is also used as a laxative and can be given as a pharmaceutical dosage for constipation. R 80123 is metabolized by conjugation with guanylate and inotropic effects are due to its ability to activate guanylate cyclase.Formula:C26H29N5O3Purity:Min. 95%Molecular weight:459.5 g/molJoining Peptide (Rat)
CAS:Joining peptide is a peptide that activates the receptor. It consists of two parts: a receptor-binding domain and a cell-penetrating domain. The receptor-binding domain is designed to bind to specific receptors on cells, while the cell-penetrating domain allows the peptide to cross the plasma membrane and penetrate into the cytoplasm. Joining peptide is used as an activator for ion channels and ligands for antibodies or receptors. Joining peptide can be used in research as a tool for investigating protein interactions, pharmacology, and cell biology.
Formula:C75H119N25O32Purity:Min. 95%Molecular weight:1,882.9 g/molPF 04449913 maleate
CAS:PF 04449913 maleate is an analog of retinoic acid, which is used in human cancer therapy. It has been shown to inhibit the proliferation of leukemia stem cells and enhance the efficacy of radiation treatment. PF 04449913 maleate has also been shown to be effective against various other types of cancer, including prostate cancer. The mechanism of action is not clear but may involve inhibition of a pump that removes retinoic acid from the cell.Formula:C25H26N6O5Purity:Min. 95%Molecular weight:490.5 g/molmonoFITC RLN1
Mono-fluoro-4-carboxylic acid, N-(3,6-dioxo-1,2,3,6-tetrahydro-7H-purin-9yl) ester (FITC RLN1) is a fluorescent ligand for the receptor. It binds to the receptor and activates it by increasing the frequency of opening of ion channels on the cell membrane. This ligand can be used as a pharmacological tool in research into ion channels and ligands.Purity:Min. 95%NGP555
CAS:NGP555 is a pharmacological agent that has been shown to have transport properties in cell culture. It is a monoclonal antibody that binds to the growth factor neurotrophin-3 (NT-3) and inhibits its activity. NGP555 is not active against liver cells, but it does have glycosidic bond and can be used in vitro assays. The pharmacokinetics study of NGP555 was conducted with humans, and this drug has been shown to have synaptic dysfunction as a side effect.Formula:C23H23FN4SPurity:Min. 95%Molecular weight:406.52 g/molNSC 23766
CAS:NSC 23766 is a chemical compound that has been shown to inhibit mitochondrial membrane potential, leading to the death of cells. This drug is used in the treatment of bowel disease and cancer. NSC 23766 inhibits il-2 receptor, an intracellular target that regulates the immune system. It also inhibits dinucleotide phosphate, which is an enzyme involved in the production of cellular energy. In addition, NSC 23766 induces axonal growth and body formation in neuronal cells. The most significant cytotoxicity has been observed in resistant mutants. Molecular docking analysis has been performed to investigate how this drug interacts with its targets at a molecular level.
Formula:C24H35N7·3HClPurity:Min. 95%Molecular weight:530.97 g/molSB 657510
CAS:SB 657510 is a pharmaceutical compound, classified as a small-molecule antiviral agent, which is derived through synthetic organic chemistry. It operates by targeting specific viral replication mechanisms, inhibiting the function of key viral enzymes necessary for the proliferation of viral particles. This mode of action disrupts the lifecycle of the virus and impairs its ability to spread within the host organism.Formula:C19H22BrClN2O5SPurity:Min. 95%Molecular weight:505.81 g/molPKUMDL WQ 2101
CAS:PKUMDL WQ 2101 is a high purity and potent inhibitor of receptor-ligand interactions. It is a small molecule that binds with high affinity to the extracellular domain of the alpha subunit of the T cell receptor (TCR) and inhibits TCR-mediated signaling. PKUMDL WQ 2101 can be used as a research tool to study protein interactions, such as those involved in signal transduction pathways. It is also an excellent ligand for binding to antibodies, peptides, and other proteins.
Formula:C14H11N3O6Purity:Min. 95%Molecular weight:317.25 g/molCYM-5442
CAS:CYM-5442 is a colony-stimulating factor that has been shown to have a variety of effects on tissue culture. It has been shown to stimulate the growth of cells in vitro, and may be used for the treatment of autoimmune diseases, cardiac problems, and inflammatory bowel disease. CYM-5442 also acts as an acylation reaction with glucose regulation in the body and can stimulate serotonin reuptake inhibition. This drug is also thought to have activity against bowel diseases such as Crohn's disease, ulcerative colitis, or irritable bowel syndrome by inhibiting toll-like receptor 4 (TLR4).Formula:C23H27N3O4Purity:Min. 95%Molecular weight:409.48 g/molLeflunomide-d4
CAS:Controlled ProductLeflunomide-d4 is a potent inhibitor of protein interactions, which has been used as a research tool to study the effects of peptides on ion channels. Leflunomide-d4 binds to peptides and interacts with them in vitro. This inhibition can be reversed by adding a specific ligand that competes with the binding site. Leflunomide-d4 is also an activator of the receptor for angiotensin II, which is involved in the regulation of blood pressure. It has been shown to inhibit the activation of some ion channels, such as those for potassium and calcium ions, although it does not inhibit other ion channels such as those for sodium and chloride ions. The molecular weight of leflunomide-d4 is 806 daltons and its CAS number is 1189987-23-2.Formula:C12H9F3N2O2Purity:Min. 95%Molecular weight:274.23 g/molPLX 51107
CAS:PLX 51107 is an anticancer agent that has been shown to inhibit the growth of urothelial carcinoma cells in vitro and in vivo. It has also been shown to have genotoxic effects on prostate cancer cells. PLX 51107 induces apoptosis through the activation of caspases and pro-apoptotic protein expression, which may be due to its ability to bind to toll-like receptor 4 (TLR4) on tumor cells. This drug has a number of beneficial effects, such as inducing cycle arrest and inhibiting cell proliferation by blocking transcriptional regulation. It also inhibits angiogenesis, which leads to tumor growth inhibition. PLX 51107 is effective against a broad range of cancers, including urothelial carcinoma, breast cancer, colon cancer, and prostate cancer. PLX 51107 is not currently approved for use in humans because it can cause gastrointestinal toxicity in rats and mice at higher doses.Formula:C26H22N4O3Purity:Min. 95%Molecular weight:438.48 g/molBAY 293
CAS:BAY 293 is a tyrosine kinase inhibitor that blocks the epidermal growth factor receptor (EGFR) and prevents it from binding to the epidermal growth factor (EGF). The BAY 293 also inhibits the activity of other protein kinases, such as Shp2, which are involved in signal transduction pathways. It has been shown to inhibit tumor formation in mice with sarcoma viral oncogene-induced tumors. BAY 293 binds covalently to the enzyme, thereby inhibiting its function. This compound has been shown to be effective against cancer cells that have overactive EGFR and Shp2 proteins.Formula:C25H28N4O2SPurity:Min. 95%Molecular weight:448.59 g/mol3-Bodipy-propanoic acid N-phenethylspiperone amide
CAS:Fluorescent analogue of SpiperoneFormula:C45H48BF3N6O3Purity:Min. 95%Molecular weight:788.71 g/molBioymifi
CAS:Bioymifi is a synthetic compound, functioning as a biological agent, which is derived from natural precursor molecules using advanced chemical synthesis techniques. It acts as a modulator of cellular pathways, specifically influencing apoptosis by selectively activating certain proteins within the cellular environment. This mode of action is particularly useful in elucidating the mechanisms of cell death and survival, thereby contributing to a deeper understanding of cellular processes.Formula:C22H12BrN3O4SPurity:Min. 95%Molecular weight:494.32 g/molProtein Kinase C (530-558)
CAS:Please enquire for more information about Protein Kinase C (530-558) including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormula:C148H220N34O51S2Nivocasan
CAS:Nivocasan is a diagnostic agent that is used to detect chronic kidney disease. It is an n-oxide compound, which is metabolized by the liver and kidneys into an active form with a molecular weight of about 300. Nivocasan binds to the nucleic acid in the cells of the nervous system, causing them to be stained by immunohistochemical staining. This drug has been shown to increase bone mass and reduce insulin resistance in rats with glucose intolerance. Hydroxy group may also play a role in its activity. Nivocasan is also being developed as a clinical drug for the treatment of nerve diseases caused by virus infections or other causes such as diabetes, stroke, and Alzheimer's disease.Formula:C21H22FN3O5Purity:Min. 95%Molecular weight:415.4 g/molWHI-P180 hydrochloride
CAS:WHI-P180 hydrochloride is a selective inhibitor of the TRPV1 ion channel. It is a potent inhibitor of TRPV1 channels and has been shown to inhibit the activation of these channels by capsaicin, low pH, and heat. WHI-P180 hydrochloride is in a class of compounds called "capsaicin analogs" because it mimics the structure of capsaicin, which activates TRPV1 channels. WHI-P180 hydrochloride has been shown to be an effective treatment for neuropathic pain that does not respond to other treatments.Formula:C16H16ClN3O3Purity:Min. 95%Molecular weight:333.77 g/molDPC AJ1951
CAS:DPC AJ1951 is a peptide that has been shown to activate the protein kinase C (PKC) pathway in various cell types, including neurons and myocytes. DPC AJ1951 is also an inhibitor of the ion channel TRPV1, which is activated by capsaicin and other irritants. This peptide may be used as a research tool to study PKC activation and TRPV1 inhibition.Formula:C76H127N23O19Purity:Min. 95%Molecular weight:1,667 g/molASP 4058
CAS:ASP 4058 is a metallo-β-lactamase inhibitor, which is derived from synthetic sources and designed to counteract the resistance mechanisms of β-lactam antibiotics. The compound operates by binding to and inhibiting metallo-β-lactamase enzymes, which are responsible for hydrolyzing and inactivating the β-lactam ring of antibiotics, rendering them ineffective against resistant bacterial strains.Formula:C19H12F6N4O2Purity:Min. 95%Molecular weight:442.3 g/molCCG 203971
CAS:Inhibits MRTF-SRF transcriptional pathway
Formula:C23H21ClN2O3Purity:Min. 95%Molecular weight:408.88 g/mol
